Clinical Trial Update: Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating saxagliptin added to metformin in type 2 diabetes patients not adequately controlled on metformin alone; the study has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Onglyza (Saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2011-04-08